Interventions and impact of pharmacist-delivered services for people infected with COVID-19: A systematic review

Ahmed, Ali, Tanveer, Maria, Shrestha, Sunil, Khatiwada, Asmita Priyadarshini, Khanal, Saval ORCID:, Dujaili, Juman Abdulelah and Paudyal, Vibhu (2022) Interventions and impact of pharmacist-delivered services for people infected with COVID-19: A systematic review. Healthcare, 10 (9). ISSN 2227-9032

[thumbnail of healthcare-10-01630]
PDF (healthcare-10-01630) - Published Version
Available under License Creative Commons Attribution.

Download (444kB) | Preview


Pharmacists are essential members of the healthcare team. The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has led pharmacists to undertake additional clinical roles. We aim to conduct a systematic review on the interventions and impact of pharmacist-delivered services in managing COVID-19 patients. We searched PubMed, Embase, Scopus, CINAHL plus, International Pharmaceutical Abstracts, and Web of Science from 1 December 2019 (the first case of COVID-19 emerged) to 13 January 2022 to retrieve the articles. Cochrane handbook and PRISMA guidelines were followed respectively to perform and report the review. The pharmacist-led interventions were reported following the Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2. The protocol of systematic review was registered on PROSPERO (CRD42021277128). Studies quality was assessed with the modified NOS scale. In total, 7 observational studies were identified from 10,838 studies. Identification of dosage errors (n = 6 studies), regimen modifications (n = 5), removal of obsolete/duplicate medications (n = 5), identification and management of adverse drug reactions (n = 4), drug interactions prevention (n = 2), and physicians acceptance rate (n = 3) of therapy-related services delivered in-person or via tele-pharmacy were among the pharmacist-delivered services. Common interventions delivered by pharmacists also included optimizing the use of antibacterial, antivirals, and anticoagulants in COVID-19 infected patients. The acceptance of pharmacist-delivered services by physicians was high (88.5–95.5%). Included studies have described pharmacists’ beneficial role in managing patients with COVID-19 including detection, resolution, and prevention of medication-related problems, with physicians demonstrating high trust in pharmacists’ advice. Future research should assess the feasibility and scalability of such roles in real-world settings.

Item Type: Article
Additional Information: Funding Information: Open access funding was provided by the University of Birmingham. We received no other funding for this project.
Uncontrolled Keywords: covid-19,medication review,pharm-d,pharmaceutical care,physician acceptance,leadership and management,health policy,health informatics,health information management,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2900/2911
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Population Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 17 Apr 2023 13:30
Last Modified: 06 Jun 2024 15:23
DOI: 10.3390/healthcare10091630


Downloads per month over past year

Actions (login required)

View Item View Item